Encompass Health CORP Form 4 insider transactions

NYSE
Encompass Health Corp. director Terrance Williams acquired 1,634 shares of common stock through an annual restricted stock unit grant.
NYSE
Encompass Health Corp. reports a Form 4 filing detailing a stock acquisition by Director Leslye G. Katz.
NYSE
Encompass Health Corp. director Joan E. Herman acquired 1,634 shares of common stock through an annual grant of restricted stock units.
NYSE
Encompass Health Corp. director Nancy M. Schlichting was granted 1,634 restricted stock units as part of an annual award.
NYSE
Director Greg D. Carmichael acquired 27 restricted stock units in Encompass Health Corp via dividend reinvestment.
NYSE
Director Edward M. Christie III acquired additional Encompass Health Corp shares through dividend reinvestment and fee deferral.
NYSE
Director Cain A. Hayes acquired 1 restricted stock unit in Encompass Health Corp via a dividend reinvestment mechanism.
NYSE
Director Joan E. Herman acquired 85 restricted stock units as part of a dividend reinvestment program.
NYSE
Director Leslye G. Katz acquired 85 restricted stock units of Encompass Health Corp via dividend reinvestment.
NYSE
Director Kevin J. O'Connor acquired 17 restricted stock units as part of a dividend reinvestment program.
NYSE
Director Christopher R. Reidy acquired additional Encompass Health common stock through dividend reinvestment and a deferred compensation plan.
NYSE
Director Nancy M. Schlichting acquired 39 restricted stock units as part of a dividend reinvestment program.
NYSE
Director Terrance Williams acquired 27 restricted stock units in Encompass Health Corp via dividend reinvestment.
NYSE
Encompass Health's Chief Accounting Officer, Andrew L. Price, disposed of 307 shares of common stock to cover tax obligations related to restricted stock vesting.
NYSE
Encompass Health's Senior Vice President and Treasurer, Edmund Fay, disposed of 280 common shares to cover tax withholding obligations related to restricted stock vesting.
NYSE
Encompass Health's Chief Medical Officer, Elissa Joy Charbonneau, disposed of 369 common shares to cover tax obligations related to restricted stock vesting.
NYSE
Encompass Health's EVP, General Counsel & Secretary, John Patrick Darby, reported the acquisition of stock options and the disposition of shares for tax obligations.
NYSE
Encompass Health Corp's President & CEO, Mark J. Tarr, reported the acquisition of stock options and the disposition of shares for tax obligations.
NYSE
Encompass Health Corp's EVP and COO, Patrick W. Tuer, reported the acquisition of stock options and the disposition of shares for tax obligations.
NYSE
Encompass Health's EVP & CFO, Douglas E. Coltharp, reported the disposition of shares for tax obligations and the acquisition of non-qualified stock options.
NYSE
Encompass Health Corp's President and CEO, Mark J. Tarr, disposed of 2,488 shares of common stock to cover tax withholding obligations related to restricted stock vesting.
NYSE
Encompass Health's Sr. Vice President and Treasurer, Edmund Fay, disposed of 380 shares to cover tax obligations from restricted stock vesting.
NYSE
Encompass Health's EVP and Chief Operating Officer, Patrick W. Tuer, executed a routine disposition of 506 common shares to satisfy tax obligations from restricted stock vesting.
NYSE
Encompass Health's EVP & CFO, Douglas E. Coltharp, disposed of 14,818 common shares to cover tax withholding obligations related to restricted stock vesting.
NYSE
Encompass Health's Chief Accounting Officer, Andrew L. Price, disposed of 404 shares of common stock to cover tax withholding obligations related to restricted stock vesting.
NYSE
Encompass Health's Chief Medical Officer, Elissa Joy Charbonneau, disposed of 440 shares of common stock to cover tax obligations related to restricted stock vesting.
NYSE
Encompass Health Corp's EVP, General Counsel, and Secretary, John Patrick Darby, disposed of 6,990 shares to cover tax withholding obligations related to restricted stock vesting.
NYSE
Encompass Health's Chief Medical Officer, Elissa Joy Charbonneau, reported the disposition of shares to cover tax obligations related to restricted stock vesting.
NYSE
Encompass Health Corp's President & CEO, Mark J. Tarr, reported the withholding of shares to cover tax obligations related to restricted stock vesting.
NYSE
Encompass Health Corp's Sr. Vice President and Treasurer, Edmund Fay, reported routine share disposals to cover tax obligations related to restricted stock vesting.